Sakar Healthcare Ltd (SAKAR) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: SAKAR | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Sakar Healthcare Ltd (SAKAR) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: SAKAR | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Sakar Healthcare

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Sakar Healthcare stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
43.98
Market Cap:
857.9 Cr.
52-wk low:
0
52-wk high:
0

Is Sakar Healthcare Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Sakar Healthcare: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sakar Healthcare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 15.3%16.1%14.2%15.5%16%13.2%12.1%9%7.4%8.5%-
Value Creation
Index
0.10.20.00.10.1-0.1-0.1-0.4-0.5-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 41.244.253.168.38394.7128133153178204
Sales YoY Gr.-7.1%20.2%28.6%21.6%14.2%35.4%4%15%15.8%-
Adj EPS 2.9334.466.68.45.44.77.88.8
YoY Gr.-4.5%-0.3%46.2%36.1%9.1%27.7%-35.4%-14.4%66.7%-
BVPS (₹) 21.532.438.34854.46374.591.1118.4128.8136.3
Adj Net
Profit
2.33.33.76.6910.314.410.310.11720
Cash Flow from Ops. 9.29.25.316.118.814.635.833.324.534-
Debt/CF from Ops. 2.12.32.80.70.92.92.63.63.22.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 17.6%16.4%11.5%15.8%
Adj EPS 11.5%5.2%-2.7%66.7%
BVPS22%18.8%20%8.7%
Share Price - 33.3% 16.8% 22.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
14.612.78.510.811.811.412.76.94.66.26.6
Op. Profit
Mgn %
20.22323.724.723.623.922.924.92528.225.3
Net Profit
Mgn %
5.77.679.710.910.911.27.86.69.69.6
Debt to
Equity
1.10.60.30.20.20.40.70.70.30.30.1
Working Cap
Days
11814416714013418416315715916877
Cash Conv.
Cycle
545461565332-7-2287014

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Sakar Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) 8.8 8.8
TTM Sales (₹ Cr.) 204 204
BVPS (₹.) 136.3 136.3
Reserves (₹ Cr.) 281 281
P/BV 2.83 2.83
PE 43.98 43.98
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 858
Equity (₹ Cr.) 22.3
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Sakar Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Sakar Healthcare - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Sakar Healthcare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales414453688395128133153178
Operating Expenses 33344151637299100115128
Manufacturing Costs4334534466
Material Costs22222835435174748482
Employee Cost 4678121314161930
Other Costs 2333456779
Operating Profit 8101317202329333850
Operating Profit Margin (%) 20.2%23.0%23.7%24.7%23.6%23.9%22.9%24.9%25.0%28.2%
Other Income 0111212531
Interest 3332223689
Depreciation 33467810151821
Exceptional Items 000000000-0
Profit Before Tax 3569121319171622
Tax 1123334444
Profit After Tax 2347101115131218
PAT Margin (%) 5.6%7.6%7.2%9.8%11.6%11.3%11.9%9.6%7.6%9.9%
Adjusted EPS (₹)2.93.13.14.56.46.98.96.75.48.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 173647728198128173258283
Share Capital 8111215151617192222
Reserves 92535576683110154236261
Minority Interest0000000000
Debt19211181540901116975
Long Term Debt1516105123885985554
Short Term Debt4513225131421
Trade Payables434452031262721
Others Liabilities 11111914141920263537
Total Liabilities 51718197115178268336389415

Fixed Assets

Gross Block536876707990235305371386
Accumulated Depreciation1519236132131385677
Net Fixed Assets 374953646669205267314309
CWIP 0009134916017
Investments 0000007300
Inventories6747111614152844
Trade Receivables35111081214222131
Cash Equivalents 0000000000
Others Assets 49138173226222515
Total Assets 51718197115178268336389415

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 99516191536332434
PBT 3369121319171622
Adjustment 55689912202529
Changes in Working Capital 11-600-741-13-14
Tax Paid -1-1-1-1-3-10-4-3-2
Cash Flow From Investing Activity -4-4-8-25-22-47-90-74-52-31
Capex -4-4-9-25-13-36-98-82-60-32
Net Investments 000000-7430
Others 0010-9-1114452
Cash Flow From Financing Activity -6-6-139332554127-3
Net Proceeds from Shares 00-413081033738
Net Proceeds from Borrowing -3-3-60000000
Interest Paid -3-3-3-2-2-2-3-5-7-8
Dividend Paid 0000000000
Others 0-00-35264713-39-3
Net Cash Flow -1-1-160-0-0-000-0

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)14.5612.839.2711.2912.5711.8913.498.485.426.48
ROCE (%)15.2916.1114.1715.4516.0213.1612.138.957.418.52
Asset Turnover Ratio0.810.730.70.760.780.650.580.440.420.44
PAT to CFO Conversion(x)4.531.252.291.91.362.42.5421.89
Working Capital Days
Receivable Days22345654394038505153
Inventory Days58553729395143405173
Payable Days415849434090123140117108

Sakar Healthcare Ltd Stock News

Sakar Healthcare Ltd FAQs

The current trading price of Sakar Healthcare on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Sakar Healthcare stood at ₹857.9.
The latest P/E ratio of Sakar Healthcare as of 31-Dec-1969 is 43.98.
The latest P/B ratio of Sakar Healthcare as of 31-Dec-1969 is 2.83.
The 52-week high of Sakar Healthcare is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sakar Healthcare is ₹204.0 ( Cr.) .

About Sakar Healthcare Ltd

Having a vision to make lives healthy, happy and more meaningful by providing healthcare solutions, Sakar Healthcare Limited, was incorporated on March 26, 2004. Subsequently, the company was converted into a public limited company and a fresh Certificate of Incorporation consequent upon change of name on Conversion to Public Limited Company dated March 27, 2015 was issued by the Registrar of Companies, Gujarat, Ahmedabad and the name of the company has got changed to 'Sakar Healthcare Limited'.

The company is managed by a team of professionals headed by its Managing Director having experience in manufacturing and export of pharmaceutical and health care products to various countries. Its preliminary business area and key focus was in contract manufacturing in the past years. As a contract manufacturer, the company undertakes manufacturing on behalf of some of the leading pharmaceutical companies in India, in accordance with the terms of the relevant agreements entered into with these companies. The company has registered its products in various countries which are marketed through supply, distribution and other arrangements with various dealers / distributors.

The company’s manufacturing facilities are located at Changodar, Ahmedabad, Gujarat. Its facilities have been approved by various international regulatory authorities such as BVQI, WHO, GM:P, CGMP and National Drug Authority of various countries including Nigeria, Ethopia, Ghana, Bolivia, Yemen and Philippines, Uganda, Ivory Coast, etc.

Business area of the company

The company is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets. Its Product domestic sales are generally exported by third party. It also undertakes contract manufacturing of formulations for pharmaceutical companies based in India. It manufactures and markets pharmaceutical formulations relating to analgesics, antielminthics, anti coagulants, anti malarial, anti spasmodics, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

 

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×